Home/ Author / Drew Meredith
    Sort By
  • Newest

  • Newest

  • Oldest

  • Author Name

  • Abbey Minogue

  • Alex Lennard

  • Amanda Mark

  • Andrew Lockhart

  • Australian Ethical

  • Bob Desmond

  • Brad Tank

  • Complii

  • Contributor

  • David Chaplin

  • David Simon

  • Drew Meredith

  • Duncan MacInnes

  • Eleanor Moriarty

  • Eleece Quilliam

  • Emanual Datt

  • Francis Gannon

  • Francyne Mu

  • George Lin

  • Giselle Roux

  • Greg Bright

  • HMC Capital

  • Helen Nan

  • Henry Maxey

  • Invesco

  • Ishan Dan

  • Jacquelyn Mann

  • James Dunn

  • Jamie Dannhauser

  • Jamie Nemtsas

  • Jasmine Yeo

  • Jaxon King

  • Joe Millward

  • Jonathan Ruffer

  • Kevin Pelham

  • Kevin Toohey

  • Kim Ivey and Michael Armitage

  • Kristina Hooper

  • Lachlan Buur-Jensen

  • Lachlan Maddock

  • Lauren French

  • Laurence Parker-Brown

  • Lisa Uhlman

  • Luke Laretive

  • Matthew O'Leary

  • Michael Armitage

  • Michael Block

  • Michael McQueen

  • Mishan Dahia

  • NIcholas Ali

  • Neuberger Berman

  • Nicholas Way

  • Nick Hatzis

  • Nick Langley

  • Nicki Bourlioufas

  • Nigel Baker

  • Owen Raszkiewicz

  • Peter McPhee

  • Peter Vala

  • Phil Strano

  • Pzena Investment Management

  • Rob Perrone, Eric Marais & Shane Woldendorp

  • Rob Prugue

  • Roy Keenan

  • Sean Graham

  • Staff Writer

  • Steve Russell

  • Tahn Sharpe

  • The Inside Adviser

  • Tim Kruger

  • Tom King

  • Will Arnost

  • Yarra Capital Management

  • All Categories

  • All Categories

  • Equities

  • In Practice

  • Growth assets

  • Asset Allocation

  • ESG

  • Economics

  • Defensive assets

  • Compliance

  • Advice

  • News

  • Launches

  • Alternatives

  • Retirement

  • Legislation

  • Fixed Income

  • Intel

  • Opinion

  • SMSF

  • Markets

  • Daily Market Update

  • Asset management

  • Industry

  • Regulation

  • Education

  • Focus

  • Investing 101

  • M&A

  • Super

  • Uncategorized

  • Analysis

  • SMSFs

Drew Meredith

Drew is editor of The Inside Network's publications and a principal adviser at Wattle Partners.

Drew Meredith results

ASX shares update; Trump bans WeChat

ASX 200 ekes out a gain, tech profit taking continues, Trump bans WeChat Global markets continued their negative trend on Friday, the ASX 200 (ASX:XJO) falling 0.3%, but managing to finish the week up a solitary 5 points; outperforming most global markets. It was a similar story in the US, with both the Nasdaq and…

Drew Meredith | 21st Sep 2020 | More
What’s better than a unicorn?

The stellar run in the Nasdaq 100 index, which has seen it reach new all-time highs some 40 times already in 2020, shows no signs of slowing. With such strength and a willingness of investors to look beyond short-term losses, a single-file, socially distanced line of “unicorns” is awaiting their piece of the action. The…

Drew Meredith | 17th Sep 2020 | More
ASX update; Alibaba on the prowl

The bull fights back, Alibaba on the prowl, Fed not enough to slow tech sell off, ASX to fall The ASX 200 (ASX:XJO) followed the strong overseas lead to finish 1.1% higher for the day. Every sector delivered a solid return, with IT, +2.4%, and Communications, +2.1%, leading the way. Employment advertising monopoly, Seek Ltd…

Drew Meredith | 16th Sep 2020 | More
ASX update; RBA minutes offer little

Lacklustre Tuesday, positive China data triggers a global rally, RBA minutes offer little The banking sector was among the weakest on Tuesday, falling 1.4%, with the ASX 200 (ASX:XJO) finishing the day flat. The Australian house price index fell 1.8% on the previous quarter, sending the Commonwealth Bank of Australia Ltd (ASX:CBA) down 1.7% as…

Drew Meredith | 15th Sep 2020 | More
ASX update; COVID-19 impacting Macquarie Group

Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…

Drew Meredith | 14th Sep 2020 | More
  • SMSF Association launches online training

    The SMSF Association have launched a comprehensive series of online modules as they seek to evolve the delivery of the SMSF Specialist Advisery (SSA) designation. The highly coveted designation requires an extensive amount of knowledge across taxation and superannuation law, which has traditionally been delivered through short study guides culminating in a detailed examination. The…

    Drew Meredith | 14th Sep 2020 | More
    ASX update; a win for ESG

    Sell off extends to four weeks, tech takes a breather, a win for ESG The ASX 200 (ASX:XJO) fell to a nine-week loss before finishing down 0.8% for the day and 1.1%; making it the fourth straight week of losses. The selling pressure was centred around financials, falling 1.2%, as geopolitical confrontations with China have…

    Drew Meredith | 13th Sep 2020 | More
    ASX update; retail pain on show at Myer (ASX:MYR)

    ASX holds onto gains, retail pain on show at Myer (ASX:MYR), another sell off to end the week The ASX 200 (ASX:XJO) managed to stave off weakness in the afternoon, finishing 0.5%, despite a much stronger lead from the US markets. The telecommunications and materials sectors including the likes of Telstra (ASX:TLS) and BHP (ASX:BHP)…

    Drew Meredith | 10th Sep 2020 | More
    ASX shares update; 9 in 10 stocks fall

    9 in 10 stocks fall, energy under pressure, but ASX to open higher after US relief As the saying goes, sharemarkets take the stairs up and the elevator down. The ASX 200 (ASX:XJO) followed the global lead finishing 2.2% lower, with all but 13 stocks in the index finishing lower. Energy companies including Woodside Petroleum…

    Drew Meredith | 9th Sep 2020 | More
    ASX shares update; US markets continue to fall

    US markets continue to fall, ASX to open lower, rent collections improve, payroll data The ASX 200 (ASX:XJO) continued its recovery, adding 1.1%, with every sector but Consumer Staples finishing higher. Healthcare was the highlight once again, CSL Ltd (ASX:CSL) continuing to see support following yesterday’s announcement of production agreements for COVID-19 vaccines, finishing 2.1%…

    Drew Meredith | 8th Sep 2020 | More
    1 59 60 61 62 63 72
    Our Authors
    Popular
  • Popular posts: